ALBI联合APRI对HBV相关肝细胞癌肝切除术后肝衰竭发生的预测价值

麦荣云; 叶甲舟; 王言焱; 白涛; 陈洁; 黄山; 邬国斌; 吴飞翔; 赵荫农; 黎乐群

doi:10.3969/j.issn.1001-5256.2018.02.015

ALBI联合APRI对HBV相关肝细胞癌肝切除术后肝衰竭发生的预测价值

DOI: 10.3969/j.issn.1001-5256.2018.02.015

广西医科大学附属肿瘤医院肝胆外科

基金项目:

国家自然科学基金(81360315)；广西卫生与计划生育委员会适宜推广技术项目(S201629)；

详细信息

中图分类号: R735.7
计量
- 文章访问数: 2560
- HTML全文浏览量: 35
- PDF下载量: 570
- 被引次数: 0
出版历程
- 出版日期: 2018-02-20

Value of albumin-bilirubin score combined with aspartate aminotransferase-to-platelet ratio index in predicting the development of posthepatectomy liver failure in patients with HBV-related hepatocellular carcinoma

Department of Hepatobiliary Surgery, The Affiliated Tumor Hospital of Guangxi Medical University

Research funding:

摘要

摘要:
目的探讨血清白蛋白-胆红素评分（ALBI）联合天冬氨酸转氨酶-血小板比值（APRI）预测HBV相关肝细胞癌（HCC）肝切除术后发生肝衰竭（PHLF）的作用。方法回顾性研究广西医科大学附属肿瘤医院2006年1月-2013年10月接受肝切除术治疗的HBV相关HCC患者,将Child-Pugh评分作为对照,评估术前ALBI、APRI、ALBI联合APRI评分预测PHLF的作用。计数资料采用χ2或Fisher确切检验,采用logistic回归模型进行多变量分析识别PHLF的独立预测指标。结果纳入本研究的1055例患者中,共有151例（14.3%）发生PHLF。单、多因素分析显示,ALBI、APRI与PHLF的患者预后有显著相关性（P值均<0.001）。ALBI和APRI的受试者工作特征曲线下面积（AUC）均显著高于Child-Pugh评分（P值均<0.001）。albi的最佳截断值为-2.77时预测phlf的灵敏度与特异度分别为78.1%、55.8%,albi>-2.77时PHLF及PHLF A/B/C的发病率明显高于该评分≤-2.77时的情况（P值均<0.001）;A...
- 癌,肝细胞 /
- 肝切除术 /
- 肝功能衰竭 /
- 危险因素
Abstract:
Objective To investigate the value of albumin-bilirubin (ALBI) score combined with aspartate aminotransferase-to-platelet ratio index (APRI) in predicting the development of posthepatectomy liver failure (PHLF) in patients with HBV-related hepatocellular carcinoma (HCC) .Methods A retrospective analysis was performed for the patients with HBV-related HCC who underwent hepatectomy in The Affiliated Tumor Hospital of Guangxi Medical University from January 2006 to October 2013.With Child-Pugh score as control, the values of ALBI, APRI, and ALBI combined with APRI in predicting PHLF were analyzed.The chi-square test or the Fisher exact test was used for comparison of categorical data between groups, and the logistic regression model was used to identify independent predictive indices for PHLF.Results A total of 1055 patients were enrolled in this study, among whom 151 (14.3%) experienced PHLF.The univariate and multivariate analyses showed that ALBI and APRI were significantly associated with the prognosis of PHLF patients (P < 0.001) .ALBI and APRI had a significantly higher area under the receiver operating characteristic curve (AUC) than Child-Pugh score (both P<0.001) .albi="" had="" a="" sensitivity="" of="" and="" specificity="" in="" predicting="" phlf="" at="" the="" optimal="" cut-off="" value="" patients="" with="" albi="">-2.77 had a significantly higher incidence rate of PHLF A/B/C than those with ALBI ≤-2.77 (P < 0.001) .APRI had a sensitivity of 61.6% and a specificity of 71.0% in predicting PHLF at the optimal cut-off value of 0.85, and the patients with APRI >0.85 had a significantly higher incidence rate of PHLF A/B/C than those with APRI ≤0.85 (P < 0.001) .The combination of ALBI and APRI had a significantly higher AUC than ALBI or APRI (P < 0.001 and P = 0.047) .The combination of ALBI and APRI had a sensitivity of 78.1% and a specificity of 62.2% in predicting PHLF at the optimal cut-off value of-13.10, and the patients with the combination of ALBI and APRI >-13.10 had a significantly higher incidence rate of PHLF A/B/C than those with the combination of ALBI and APRI ≤-13.10 (P < 0.001) .Conclusion ALBI combined with APRI can be used as a new, convenient, and reliable index for predicting PHLF.
- carcinoma, hepatocellular /
- hepatectomy /
- liver failure /
- risk factors

HTML全文

参考文献(27)

[1]TORRE LA, BRAY F, SIEGEL RL, et al.Global cancer statistics, 2012[J].CA Cancer J Clin, 2015, 65 (2) :87-108.

[2]CHU KK, CHEUNG TT.Update in management of hepatocellular carcinoma in Eastern population[J].World J Hepatol, 2015, 7 (11) :1562-1571.

[3]BRUIX J, SHERMAN M.Management of hepatocellular carcinoma:an update[J].Hepatology, 2011, 53 (3) :1020-1022.

[4]EL-SERAG HB.Hepatocellular carcinoma[J].N Engl J Med, 2011, 365 (12) :1118-1127.

[5]LIN F.Research advances in clinical diagnosis, prognostic evaluation, and treatment of liver failure[J].J Clin Hepatol, 2016, 32 (9) :1678-1683. (in Chinese) 林锋.肝衰竭的临床诊断、预后评估和治疗进展[J].临床肝胆病杂志, 2016, 32 (9) :1678-1683.

[6]Mc CORMACK L, PETROWSKY H, JOCHUM W, et al.Hepatic steatosis is a risk factor for postoperative complications after major hepatectomy:a matched case-control study[J].Ann Surg, 2007, 245 (6) :923-930.

[7]DURAND F, VALLA D.Assessment of the prognosis of cirrhosis:Child-Pugh versus MELD[J].J Hepatol, 2005, 42 (Suppl 1) :s100-s107.

[8]JOHNSON PJ, BERHANE S, KAGEBAYASHI C, et al.Assessment of liver function in patients with hepatocellular carcinoma:a new evidence-based approach-the ALBI grade[J].J Clin Oncol, 2015, 33 (6) :550-558.

[9]WANG YY, ZHONG JH, SU ZY, et al.Albumin-bilirubin versus Child-Pugh score as a predictor of outcome after liver resection for hepatocellular carcinoma[J].Br J Surg, 2016, 103 (6) :725-734.

[10]WAI CT, GREENSON JK, FONTANA RJ, et al.A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C[J].Hepatology, 2003, 38 (2) :518-526.

[11]CASTERA L, VERGNIOL J, FOUCHER J, et al.Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C[J].Gastroenterology, 2005, 128 (2) :343-350.

[12]ICHIKAWA T, UENISHI T, TAKEMURA S, et al.A simple, noninvasively determined index predicting hepatic failure following liver resection for hepatocellular carcinoma[J].J Hepatobiliary Pancreat Surg, 2009, 16 (1) :42-48.

[13]BERZIGOTTI A, REIG M, ABRALDES JG, et al.Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis:a systematic review and meta-analysis[J].Hepatology, 2015, 61 (2) :526-536.

[14]RAHBARI NN, GARDEN OJ, PADBURY R, et al.Posthepatectomy liver failure:a definition and grading by the International Study Group of Liver Surgery (ISGLS) [J].Surgery, 2011, 149 (5) :713-724.

[15]DINDO D, DEMARTINES N, CLAVIEN PA.Classification of surgical complications:a new proposal with evaluation in a cohort of6336 patients and results of a survey[J].Ann Surg, 2004, 240 (2) :205-213.

[16]PUTTER H, FIOCCO M, GESKUS RB.Tutorial in biostatistics:competing risks and multi-state models[J].Stat Med, 2007, 26 (11) :2389-2430.

[17]LI FW, LEI ZQ, ZHANG QQ, et al.Establishment of nomogram model for predicting posthepatectomy liver failure in patients with HBV-related hepatocellular carcinoma[J/CD].Chin J Hepatic Surg:Electronic Edition, 2017, 6 (5) :358-362. (in Chinese) 李风伟, 雷正清, 张茜茜, 等.预测HBV相关肝细胞癌肝切除术后肝衰竭列线图模型的建立[J/CD].中华肝脏外科手术学电子杂志, 2017, 6 (5) :358-362.

[18]WIESNER R, EDWARDS E, FREEMAN R, et al.Model for end-stage liver disease (MELD) and allocation of donor livers[J].Gastroenterology, 2003, 124 (1) :91-96.

[19]CHEN RC, CAI YJ, WU JM, et al.Usefulness of albumin-bilirubin grade for evaluation of long-term prognosis for hepatitis B-related cirrhosis[J].J Viral Hepat, 2017, 24 (3) :238-245.

[20]KUO YH, WANG JH, HUNG CH, et al.The ALBI grade predicts the prognosis of patients with advanced hepatocellular carcinoma received sorafenib[J].J Gastroenterol Hepatol, 2017.[Epub ahead of print]

[21]HIRAOKA A, KUMADA T, MICHITAKA K, et al.Usefulness of albumin-bilirubin grade for evaluation of prognosis of 2584 Japanese patients with hepatocellular carcinoma[J].J Gastroenterol Hepatol, 2016, 31 (5) :1031-1036.

[22]DIENSTAG JL.The role of liver biopsy in chronic hepatitis C[J].Hepatology, 2002, 36 (5 Suppl 1) :s152-s160.

[23]LOAEZA-DEL-CASTILLO A, PAZ-PINEDA F, OVIEDOCARDENAS E, et al.AST to platelet ratio index (APRI) for the noninvasive evaluation of liver fibrosis[J].Ann Hepatol, 2008, 7 (4) :350-357.

[24]SOOKOIAN S, CASTANO GO, SCIAN R, et al.Serum aminotransferases in nonalcoholic fatty liver disease are a signature of liver metabolic perturbations at the amino acid and Krebs cycle level[J].Am J Clin Nutr, 2016, 103 (2) :422-434.

[25]OKUDA M, LI K, BEARD MR, et al.Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein[J].Gastroenterology, 2002, 122 (2) :366-375.

[26]SHEN SL, FU SJ, CHEN B, et al.Preoperative aspartate aminotransferase to platelet ratio is an independent prognostic factor for hepatitis B-induced hepatocellular carcinoma after hepatic resection[J].Ann Surg Oncol, 2014, 21 (12) :3802-3809.

[27]CHENG J, ZHAO P, LIU J, et al.Preoperative aspartate aminotransferase-to-platelet ratio index (APRI) is a predictor on postoperative outcomes of hepatocellular carcinoma[J].Medicine (Baltimore) , 2016, 95 (48) :e5486.

施引文献

资源附件(0)

访问统计